Regulus Therapeutics
RGLS
#8864
Rank
ยฃ82.83 M
Marketcap
ยฃ1.26
Share price
2.58%
Change (1 day)
22.59%
Change (1 year)

Regulus Therapeutics (RGLS) - Cash on Hand

Cash on Hand as of September 2024 : ยฃ69.44 Million

According to Regulus Therapeutics's latest financial reports the company has ยฃ69.44 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Regulus Therapeutics - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31ยฃ32.36 M-27.64%
2021-12-31ยฃ44.73 M96.14%
2020-12-31ยฃ22.8 M-12.35%
2019-12-31ยฃ26.02 M137.03%
2018-12-31ยฃ10.97 M-75.3%
2017-12-31ยฃ44.44 M-27.94%
2016-12-31ยฃ61.68 M-19.86%
2015-12-31ยฃ76.96 M-24.98%
2014-12-31ยฃ0.10 B48.45%
2013-12-31ยฃ69.11 M13.87%
2012-12-31ยฃ60.69 M147.32%
2011-12-31ยฃ24.54 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
ยฃ3.41 B 4,823.57%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ5.79 B 8,242.93%๐Ÿ‡ซ๐Ÿ‡ท France
ยฃ1.35 B 1,846.19%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ3.92 B 5,546.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ2.21 B 3,084.37%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ31.17 M-55.10%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ6.43 B 9,170.52%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA